Hydrophilic Angiographic Catheters Market Report 2026

Hydrophilic Angiographic Catheters Market Overview

• Hydrophilic Angiographic Catheters market size has reached to $13.54 billion in 2025 • Expected to grow to $19.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Increasing Prevalence Of Renal Disorders Driving Growth In The Hydrophilic Angiographic Catheters Market • Market Trend: Advancements For Hydrophilic Angiographic Catheters • Asia-Pacific was the largest region in 2025.

What Is Covered Under Hydrophilic Angiographic Catheters Market?

Hydrophilic angiographic catheters are specialized medical devices used in interventional radiology and cardiology. They feature a hydrophilic coating that significantly reduces friction, enabling smoother navigation through complex vascular pathways. These catheters facilitate easier handling and control during diagnostic and therapeutic procedures for cardiovascular diseases. The main types of hydrophilic angiographic catheters are selective type angiographic catheters and non-selective type angiographic catheters. Selective catheters are designed for targeted access to specific blood vessels. They have a variety of tip shapes and curves to navigate complex vascular anatomy and engage target vessel ostia. These are used in various applications, including heart disease treatment, kidney disease treatment, and others, by a variety of end users, such as hospitals, diagnostic and imaging centers, and others.

What Is The Hydrophilic Angiographic Catheters Market Growth Forecast?

The hydrophilic angiographic catheters market size is expected to see strong growth in the next few years. It will grow to $19.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for minimally invasive interventions, technological innovation in hydrophilic coating technologies, growth in interventional cardiology and radiology, increasing healthcare expenditure on cardiac care, expanding access to advanced imaging and catheterization labs. Major trends in the forecast period include increasing use of hydrophilic coatings for reduced friction, rising adoption in minimally invasive cardiovascular procedures, growing preference for selective angiographic catheters, improved catheter trackability in complex vascular anatomy, enhanced focus on procedural safety and physician control.

Global Hydrophilic Angiographic Catheters Market Segmentation

1) By Type: Selective Type Angiographic Catheters, Non-Selective Type Angiographic Catheters 2) By Application: Heart Disease Treatment, Kidney Disease Treatment, Other Applications 3) By End User: Hospitals, Diagnostic And Imaging Centers, Other End-Users Subsegments: 1) By Selective Type Angiographic Catheters: Coronary Selective Catheters, Peripheral Selective Catheters, Neuro Selective Catheters 2) By Non-Selective Type Angiographic Catheters: Non-Selective Coronary Catheters, Non-Selective Peripheral Catheters, Non-Selective Neuro Catheters

What Is The Driver Of The Hydrophilic Angiographic Catheters Market?

The growth in the prevalence of renal disorders is expected to propel the growth of the hydrophilic angiographic catheters market going forward. Renal disorders refer to a broad category of conditions that affect the kidneys, impairing their ability to filter blood, remove waste, balance fluids and electrolytes, and regulate blood pressure. Renal disorders are growing primarily due to the increasing prevalence of risk factors such as diabetes, hypertension, and aging populations. Hydrophilic angiographic catheters are used in renal disorders for precise and smooth navigation during diagnostic and interventional procedures, such as renal artery angiography and stenting. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the growth in the prevalence of renal disorders is driving the hydrophilic angiographic catheters industry.

Key Players In The Global Hydrophilic Angiographic Catheters Market

Major companies operating in the hydrophilic angiographic catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Cook Medical Inc., Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Asahi Intecc Co Ltd., AngioDynamics Inc., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Invamed Group

Global Hydrophilic Angiographic Catheters Market Trends and Insights

Major companies in the hydrophilic angiographic catheters market focus on developing innovative products such as catheters with various curve configurations to sustain their position in the market. Catheters with various curve configurations are specialized medical devices designed with different bending or curving shapes to navigate complex anatomical structures. For instance, in January 2024, Cook Group Incorporated, a US-based medical device company, launched its Slip-Cath Beacon Tip hydrophilic selective catheter in the USA and Canada. Designed for use in both vascular and non-vascular angiographic procedures, this catheter features over 30 different curve configurations and comes in protective foil packaging to ensure extended durability and a three-year shelf life. Its advanced technology enhances usability during procedures, and it is intended to work seamlessly with vascular access sheaths, wire guides, and various treatment devices.

What Are Latest Mergers And Acquisitions In The Hydrophilic Angiographic Catheters Market?

In April 2024, Shenzhen Mindray Technology Holdings Co. Ltd., a China-based medical device company, acquired a 19.72% stake in APT Medical for $927 million. This acquisition positions Mindray as a significant player in the cardiovascular medical device market, allowing it to leverage APT Medical's expertise in areas such as cardiac electrophysiology and vascular interventions. APT Medical is a China-based medical device company that provides hydrophilic angiographic catheters.

Regional Outlook

Asia-Pacific was the largest region in the hydrophilic angiographic catheters market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hydrophilic Angiographic Catheters Market?

The hydrophilic angiographic catheters market consists of sales of guidewire, imaging equipment, contrast media injectors, and control and steering devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.